Form D — Savanna Biotherapeutics, Inc.
0001873404-25-000002 · filed Jun 30, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $59,999,993
- Reported amount sold
- $12,999,997
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Savanna Biotherapeutics, Inc.
- CIK
- 1873404
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- C/O UNIVERSITY LAB PARTNERS, CURIE HALL
ALISO VIEJO, California 92656 - Phone
- 716-969-2573
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Spitale · Executive OfficerAliso Viejo, California Find on LinkedIn ↗
-
Jeffrey W. Bird · DirectorPalo Alto, California Find on LinkedIn ↗
-
Keith Loebner · DirectorPalo Alto, California Find on LinkedIn ↗
-
Kim Kamdar · DirectorNissequogue, New York Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗